%0 Journal Article
%T Some Haematological and Biochemical Investigations on Duck Virus Hepatitis following Administration of Glycyrrhizin
%A Faten A. Okda
%A Safaa Yassein
%A Alaa R. Ahmed
%A Hamdy Soufy
%A Soad M. Nasr
%J ISRN Pharmacology
%D 2013
%R 10.1155/2013/849412
%X The present study aimed to investigate the protective effect of glycyrrhizin (locally isolated and purified from licorice root) against duck hepatitis virus through the assessment of some hematological and biochemical parameters. One hundred and sixty white Pekin ducklings¡ªone day old¡ªwere randomly divided into four equal groups. Group (1) was kept as normal control. Group (2) was inoculated I/P with 10£¿mg glycyrrhizin/kg BW, three times per week for four weeks. Group (3) was inoculated I/M with 0.5£¿ml of live attenuated DHV vaccine. Group (4) was inoculated with both glycyrrhizin (10£¿mg/kg BW I/P, three times per week for four weeks) and live attenuated DHV vaccine (0.5£¿ml, I/M). Then, all groups of treatment were challenged using virulent DHV except for 20 ducklings from the normal control group which were continued to be kept as negative control. The results revealed that duck hepatitis virus (DHV) caused macrocytic hypochromic anemia, leukopenia, hypoproteinemia, hypoalbuminemia, hyperglycemia, hypercholesterolemia, and marked elevation of liver enzymes and renal parameters. In conclusion, glycyrrhizin injected alone or in combination with DHV vaccine protected or ameliorated the deteriorating effects induced by DHV vaccine and/or duck hepatitis virus infection by improvement of erythrogram and leukogram, as well as liver and kidney functions. 1. Introduction Duck virus hepatitis (DVH) is one of the most economic import diseases to all duck-growing farms because of its high potential mortality if the infection is not controlled. It is an acute highly fatal rapidly spreading viral infection of young ducklings. It was first recoded in New York and Taiwan. The morbidity is 100% and the mortality may reach 95¨C100%, in the first week of age [1]. Survived ducklings after DHV infection have a solid immunity, but it is necessary to protect the duck industry against such fatal disease using the potent-specific vaccine. Live attenuated DVH-1 vaccine which could be administrated through the intramuscular route in breeder ducks 2-3 weeks before lying allowing the transmission of high maternal immunity to the offspring providing them with passive immunity that is able to protect the new hatched birds up to 15 days of age. Also, it could be injected in 2-day-old ducklings followed by a booster dose 2-3weeks later [2]. In Egypt, duck farms are routinely protected against DVH following a vaccination program employing DVH-1 which is the only vaccine recorded in Egypt. Unfortunately, some duck farms stopped vaccination against DVH causing the recurrence of disease
%U http://www.hindawi.com/journals/isrn.pharmacology/2013/849412/